Fatal B-cell lymphoproliferative syndrome in allogeneic marrow graft recipients

Arnold R, Schmeiser T, Friedrich W, Carbonell F, Goldmann SF, Heit W, Kohne E, Kurrle E, Röttinger E, Wannenmacher M, Fliedner TM, Kleihauer E, Heimpel H, Kubanek B (1984) Knochenmarkstransplantation bei Panmyelopathie, akuter Leukämie und chronisch-myeloischer Leukämie: Ergebnisse der Ulmer Transplantationsgruppe. Klin Wochenschr 62:577–585 Atkinson K, Biggs JC, Ting A, Concannon AJ, Dodds AJ, Pun A (1983) Cyclosporin A is associated with faster engraftment and less mucositis than methotrexate after allogeneic bone marrow transplant. Br J Haematol 53:265–270 Autenrieth JB, Borisch B, Schmeiser T, Arnold R, Jahn G, Müller-Hermelink HK, Heymer B (1989) Validity of immunohistology and in-situ hybridization in the differential diagnosis of cytomegalovirus pneumonia and idiopathic interstitial pneumonia after allogeneic bone marrow transplantation. Immun Infekt 17:100–108 Bakshi A, Minowada J, Arnold A, Cossman G, Jensen JP, Whang-Peng J, Waldman TA, Korsmeyer SJ (1983) Lymphoid blast crisis of chronic myelogenous leukemia represent stages in the development of B cell precursors. N Engl J Med 309:826–831 Beveridge T, Krupp P, McKibbin C (1984) Lymphomas and lymphoproliferative lesions developing under cyclosporin therapy. Lancet 1:788 Bieber CP, Reitz BA, Jamieson SW, Oyer PE, Stinson EB (1980) Malignant lymphoma in cyclosporin A treated allograft recipients. Lancet 1:43 Billaud M, Rousset F, Calender A, Cordier M, Aubry JP, Laisse V, Lenoir GM (1990) Low expression of lymphocyte functionassociated antigen (LFA)-l and LFA-3 adhesion molecules is a common trait in Burkitt’s lymphoma associated with and not associated with Epstein-Barr virus. Blood 75:1827–1833 Bloom RE, Brennan JK, Sullivan JL, Chiganti RSK, Dinsmore R, O’Reilly R (1985) Lymphoma of host origin in a marrow transplant recipient in remission of acute myeloid leukemia and receiving cyclosporin A. Am J Hematol 18:73–83 Boehm T, Buluwela L, Williams D, White L, Rabbits TH (1988) A cluster of chromosome 11 p13 translocations found via distinct D-D and D-D-J rearrangements of the human T cell receptorδ chain gene. EMBO J 7:2011–2017 Borisch Chappuis B, Müller H, Stutte J, Hey MM, Hübner K, Müller-Hermelink HK (1990 a) Identification of EBV-DNA in lymph nodes from patients with lymphadenopathy and lymphomas associated with AIDS. Virchows Archiv [B] 58:199–205 Borisch-Chappuis B, Nezelof C, Müller H, Müller-Hermelink HK (1990 b) Different Epstein-Barr virus expression in lymphomas from immunocompromised and immunocompetent patients. Am J Pathol 136:751–758 Calne RY, Rolles K, Thiru S, McMaster P, Craddock GN, Aziz S, White DJG, Evans DB, Dunn DC, Henderson RG, Lewis P (1979) Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreas, and 2 livers. Lancet II: 1033–1036 Cen H, Breinig MC, Atchison RW, Ho M, McKnight JLC (1991) Epstein-Barr virus transmission via the donor organs in solid organ transplantation: Polymerase chain reaction and restriction fragment length polymorphism analysis of IR2, IR3, and IR4. J Virol 65:976–980 Cleary ML, Sklar J (1984) Lymphoproliferative disorders in cardiac transplant recipients are multiclonal lymphomas. Lancet 2:489–493 Crawford DH, Mulholland N, Iliescu V, Hawkins R, Powles R (1986) Epstein-Barr virus infection and immunity in bone marrow transplant recipients. Transplantation 42:50–54 Croce CM, Nowell PC (1985) Molecular basis of human B-cell neoplasia. Blood 65:1–7 Davey MP, Waldmann TA (1986) Clonality and lymphoproliferative lesions. N Engl J Med 315:509–511 Davey DD, Kamat D, Laszewski M, Goeken JA, Kemp JD, Trigg ME, Purtilo DT, Davis J, Dick FR (1989) Epstein-Barr virusrelated lymphoproliferative disorders following bone marrow transplantation: An immunologic and genotypic analysis. Mod Pathol 2:27–34 Deeg HJ, Sanders J, Martin P, Fefer A, Neiman P, Singer J, Storb R, Thomas ED (1984) Secondary malignancies after marrow transplantation. Exp Hematol 12:660–666 Faure P, D’Agay MF, Tricot G, Gluckman E, Brocheriou C (1986) Lymphome immunoblastique après greffe de moelle osseuse. A propos d’un cas traité par anticorps monoclonaux OKT3 pour réaction aigue du greffon contre l’hôte. Ann Pathol 6:137–143 Fischer A, Blanche S, Le Bidois J, Bordigoni P, Gamier JL, Niaudet P, Morinet F, Le Deist F, Fischer AM, Griscelli C, Hirn M (1991) Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation. N Engl J Med 324:1451–1456 Fishleder A, Tubbs R, Hesse B, Levine H (1987) Uniform detection of immunoglobulin-gene rearrangement in benign lymphoepithelial lesions. N Engl J Med 316:1118–1121 Friedrich W, Goldman SF, Ebell W, Blütters-Sawatzki R, Gaedicke G, Raghavachar A, Peter HH, Belohradsky B, Kreth W, Kubanek B, Kleihauer E (1985) Severe combined immunodeficiency: treatment by bone marrow transplantation in 15 infants using HLA-haploidentical donors. Eur J Pediatr 144:125–130 Frizzera G (1990) Lymphoproliferations in HIV-infected patients. Clinical data, pathology and pathogenesis. Blut 61:133 [Abstr 250] Frizzera G, Hanto DW, Gajl-Peczalska KJ, Rosai J, McKenna RW, Sibley RK, Holahan KP, Lindquist LL (1981) Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients. Cancer Res 41:4262–4278 Ganser A, Carlo-Stella C, Bartram CR, Boehm T, Heil G, Henglein B, Müller H, Raghavachar An, v. Briesen H, Griesinger F, Völkers B, Ruebsamen-Waigmann H, Helm EB, Hoelzer D (1988) Establishment of two Epstein-Barr virus negative Burkitt cell lines from a patient with AIDS and B-cell lymphoma. Blood 72:1255–1260 Garcia CR, Brown NA, Schreck R, Stiehm ER, Hudnall SD (1987) B-cell lymphoma in severe combined immunodeficiency not associated with the Epstein-Barr virus. Cancer 60:2941–2947 Gatti RA, Good RA (1971) Occurrence of malignancy in immunodeficiency diseases. Cancer 28:89–98 Ghory P, Schiff S, Buckley R (1986) Appearance of multiple benign paraproteins during early engraftment of soy lectin T cell-depleted haploidentical bone marrow cells in severe combined immunodeficiency. J Clin Immunol 6:161–169 Gregory CD, Murray RJ, Edwards CF, Rickinson AB (1988) Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus-positive Burkitt’s lymphoma underlies tumor cell escape from virus-specific T cell surveillance. J Exp Med 167:1811–1824 Hale G, Bright S, Chumbley G, Hoang T, Metcalf D, Munro AJ, Waldmann H (1983) Removal of T cells from bone marrow for transplantation. A monoclonal anti-lymphocyte antibody that fixes human complement. Blood 62:873–882 Hamilton-Dutoit SJ, Pallesen G, Karkov J, Shinhoj P, Franzmann MB, Pedersen C (1989) Identification of EBV-DNA in tumour cells of AIDS-related lymphomas by in-situ hybridization. Lancet I:554–555 Hanto DW, Frizzera G, Gajl-Paczalska KJ, Sakamoto K, Purtilo DT, Balfour HH, Simmons RL, Najarian JS (1982) Epstein-Barr virus-induced B-cell lymphoma after renal transplantation. N Engl J Med 306:913–918 Hanto DW, Gajl-Peczalska KJ, Frizzera G, Arthur DC, Balfour HH, McClain K, Simmons RL, Najarian JS (1983) Epstein-Barr virus induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Ann Surg 198:356–369 Hanto DW, Frizzera G, Gajl-Peczalska KJ, Simmons RL (1985) Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation. Transplantation 39:461–472 Hanto DW, Birkenbach M, Frizzera G, Gaijl-Peczalska KJ, Simmons RL, Schubach WH (1989) Confirmation of the heterogeneity of posttransplant Epstein-Barr virus-associated B cell proliferations by immunoglobulin gene rearrangement analyses. Transplantation 47:458–464 Henle G, Henle W (1966) Immunofluorescence in cells derived from Burkitt’s lymphoma. J Bacteriol 91:1248–1256 Heymer B, Krüger G, Arnold R, Schmeiser T, Friedrich W, Kubanek B, Heimpel H (1984) GvH reaction and morphology of bone marrow after allogeneic bone marrow transplantation. In: Lennert K, Hübner K (eds) Pathology of the bone marrow. Fischer, Stuttgart, p 281 Ho M, Miller G, Atchinson RW, Breinig MK, Dummer JS, Andiman W, Starzl TE, Eastman R, Griffith BP, Hardesty RL, Bahnson HT, Hakala TR, Rosenthal JT (1985) Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: The role of primary infection. J Infect Dis 152:876–886 Ho M, Jaffe R, Miller G, Breinig MK, Dummer JS, Makowka L, Atchinson RW, Karrer F, Nalesnik MA, Starzl TE (1988) The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children. Transplantation 45:719–727 Hong R, Gilbert EF, Opitz JM (1985) Omenn disease termination in lymphoma. Pediatr Pathol 3:143–154 Joncas JH, Russo P, Brochu P, Simard P, Brisebois J, Dubé J, Marton D, Leclerc JM, Hume H, Rivard GE (1990) Epstein-Barr virus polymorphic B-cell lymphoma associated with leukemia and with congenital immunodeficiencies. J Clin Oncol 8:378–383 Kapoor N, Jung LKL, Engelhard D, Filler J, Shalit I, Landreth KS, Good RA (1986) Lymphoma in a patient with severe combined immunodeficiency with adenosine deaminase deficiency, following unsustained engraftment of histoincompatible T-cell-depleted bone marrow. J Pediatr 108:435–438 Katz BZ, Raab-Traub N, Miller G (1989) Latent and replicating forms of Epstein-Barr virus DNA in lymphomas and lymphoproliferative diseases. J Infect Dis 160:589–598 Klein G (1989) Lymphoma development in mice and humans: Diversity of initiation is followed by convergent cytogenetic evolution. Proc Natl Acad Sci USA 76:2442–2446 Klein G (1989) Viral latency and transformation: the strategy of Epstein-Barr virus. Cell 58:5–8 Knowles DM, Inghirami G, Ubriaco A, Dalla-Favera R (1989) Molecular genetic analysis of three AIDS-associated neoplasms of uncertain lineage demonstrates their B-cell derivation and the possible pathogenetic role of the Epstein-Barr virus. Blood 73:792–799 Kundu SK, Menezes J (1989) Interleukin-2 induced killer cell activity against Epstein-Barr virus-immortalized human B cells. Immunol Lett 20:299–304 Lange B, Henle W, Meyers JD, Yang LC, August C, Koch P, Arbeter A, Henle G (1980) Epstein-Barr virus-related serology in marrow transplant recipients. Int J Cancer 26:151–157 Lenoir GM, Bornkamm GW (1987) Burkitt’s lymphoma, a human cancer model for the study of the multistep development of cancer: proposal for a new scenario. In: Klein G (ed) Adv Viral Oncol. Raven Press, New York 7:173–205 Levy N, Nelson J, Meyer P, Lukes RJ, Parker JW (1983) Reactive lymphoid hyperplasia with single class (monoclonal) surface immunoglobulin. Am J Clin Pathol 80:300–308 Lubbe WJ (1985) Clonality of benign lymphoid proliferations. Hum Pathol 16:650 Ludwig WD, Bartram CR, Harbott J, Köller U, Haas OA, Hansen-Hagge T, Heil G, Seibt-Jung H, Teichmann JV, Ritter J, Knapp W, Gadner H, Thiel E, Riehm H (1989) Phenotypic and genotypic heterogeneity in infant acute leukemia. I. Acute lymphoblastic leukemia. Leukemia 3:431–439 Magrath I (1989) Infectious mononucleosis and malignant neoplasia. In: Schlossberg D (ed) Infectious mononucleosis, 2nd ed. Springer, Berlin Heidelberg New York Tokyo, pp 142–171 Martin PJ, Shulman HM, Schubach WH, Hansen JA, Fefer A, Miller G, Thomas ED (1984) Fatal Epstein-Barr virus associated proliferation of donor B-cells after treatment of acute graftversus-host disease with a murine anti-T-cell antibody. Ann Int Med 101:310–315 Meyers JD, Flournoy N, Thomas ED (1986) Risk factors for cytomegalovirus infection after human marrow transplantation. J Inf Dis 153:478–488 Misko IS, Moss DJ, Pope JH (1980) HLA antigen-related restriction of T lymphocyte cytotoxicity to Epstein-Barr virus. Proc Natl Acad Sci USA 77:4247–4250 Morinet F, Icart J, Ruelle C, Gluckman E, Perol Y (1986) Epstein-Barr virus serology in bone marrow transplantations: A oneyear retrospective study with detection of EBV IgM-VCA-specific antibodies. J Med Virology 18:349–360 Nalesnik MA, Jaffe R, Starzel TE, Demetris AJ, Porter K, Burnham JA, Makowka L, Ho, M, Locker J (1988) The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol 133:173–192 Neudorf SML, Filipovich AH, Kersey JH (1984) Immunoconstitution by bone marrow transpolantation decreases lymphoproliferative malignancies in Wiskott-Aldrich and severe combined immune deficiency syndromes. In: Purtilo DT (ed) Immune deficiency and cancer, Epstein-Barr virus and lymphoproliferative malignancies. Plenum Medical Book Company, New York-London, pp 471–480 Okano M, Osato T, Koizumi S, Imai S, Aya T, Fujiwara S, Mizuno F, Sakiyama Y, Matsumoto S, Sugawara O, Uchida K, Miwa M, Hirai K, Miyashita T, Twata C (1986) Epstein-Barr virus infection and oncogenesis in primary immunodeficiency. AIDS Res [Suppl1] 2:115–119 Okano M, Taguchi Y, Nakamine H, Pirruccello SJ, Davis JR, Beisel KW, Kleveland KL, Sanger WG, Fordyce RR, Purtilo DT (1990) Characterization of Epstein-Barr virus-induced lymphoproliferation derived from human peripheral blood mononuclear cells transferred to severe combined immunodeficient mice. Am J Pathol 137:517–522 Patton DF, Wilkowski CW, Hanson CA, Shapiro R, Gajl-Peczalska KJ, Filipovich AH, McClain KL (1990) Epstein-Barr virusdetermined clonality in posttransplant lymphoproliferative disease. Tansplantation 49:1080–1084 Penn I, Hammond W, Brettschneider L, Starzl TE (1968) Malignant lymphomas in transplantation patients. Transplant Proc 1:106–112 Purtilo DT (1980) Epstein-Barr-virus-induced oncogenesis in immunedeficient individuals. Lancet I:300–303 Purtilo DT (1981) Immune deficiency predisposing to Epstein-Barr virus-induced lymphoproliferative diseases: the X-linked lymphoproliferative syndrome as a model. In: Klein G, Weinhouse S (eds) Adv Cancer Res, vol 34. Academic Press, New York pp 279–312 Raghavachar A, Bartram CR, Ganser A, Heil G, Kleihauer E, Kubanek B (1986) Acute undifferentiated leukemia: implications for cellular origin and clonality suggested by analysis of surface markers and immunoglobulin gene rearrangement. Blood 68:658–662 Reedman BM, Klein G (1973) Cellular localization of an Epstein-Barr virus (EBV) associated complement-fixing antigene in producer and non-producer lymphoblastoid cell lines. Int J Cancer 11:499–520 Rickinson AB (1990) The role of EBV in the pathogenesis of malignant lymphomas. Blut 61:71 [Abstr 3] Rickinson AB, Wallace LE, Epstein MA (1980) HLA-restricted T cell recognition of Epstein-Barr virus infected B cells. Nature 283:865–867 Rosen A, Gergely M, Jondal M, Klein G (1977) Polyclonal Ig production after Epstein-Barr virus infection in human lymphocytes in vitro. Nature 267:52–54 Rosenberg NL, Hochberg FH, Miller G, Kleinschmidt-DeMasters BK (1986) Primary central nervous system lymphoma related to Epstein-Barr virus in a patient with acquired immune deficiency syndrome. Ann Neurol 20:98–102 Rowe M, Rowe DT, Gregory CD, Young LS, Farrell PJ, Rupani H, Rickinson AB (1987) Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt’s lymphoma cells. EMBO J 6:2743–2751 Saemundsen AK, Berkel AI, Henle W, Henle G, Anvret M, Sanal O, Ersoy F, Caglar M, Klein G (1981) Epstein-Barr virus carrying lymphoma in a patient with ataxia-teleangiectasia. Br Med J 282:425–427 Sanders JE (1990) Late effect following marrow transplantation. In: Johnson F, Pochedly C (eds) Bone marrow transplantation in children. Raven Press, New York, pp 471–496 Schlossberg D (1989) Infectious mononucleosis, 2nd edit. Springer, Berlin Heidelberg New York Tokyo Schubach WH, Hackman R, Neiman PE, Miller G, Thomas TE (1982) A monoclonal immunoblastic sarcoma in donor cells bearing Epstein-Barr virus genomes following allogeneic marrow grafting for acute lymphoblastic leukemia. Blood 60:180–187 Schubach WH, Miller G, Thomas ED (1985) Epstein-Barr virus genomes are restricted to secondary neoplastic cells following bone marrow transplantation. Blood 65:535–538 Shapiro RS (1990) Epstein-Barr virus-associated B-cell lymphoproliferative disorders in immunodeficiency: Meeting the challenge. J Clin Oncol 8:371–373 Shapiro RS, McClain K, Frizzera G, Gajl-Peczalska KJ, Kersey JH, Blazar BR, Arthur DC, Patton DF, Greenberg JS, Burke B, Ramsey NKC, McGlave P, Filipovich AH (1988 a) Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation. Blood 71:1234–1243 Shapiro RS, Chauvenet A, McGuire W, Pearson A, Craft AW, McGlave P, Filipovich A (1988b) Treatment of B-cell lymphoproliferative disorders with interferon alfa and intravenous gamma globulin. N Engl J Med 318:1334 Shearer WT, Ritz J, Finegold MJ, Guerra IC, Rosenblatt HM, Lewis DE, Pollack MS, Taber LH, Sumaya CV, Grumet C, Cleary ML, Warnke R, Sklar J (1985) Epstein-Barr virus-associated B-cell proliferation of diverse clonal origins after bone marrow transplantation in a 12-year-old patient with severe combined immunodeficiency. N Engl J Med 312:1151–1159 Simon M, Neumann R, Bültmann B (1991) Demonstration of Epstein-Barr viral DNA in paraffin-embedded specimens of lymphoproliferative syndrome: Evidence for a productive infection comparable to lymphoblastoid cell lines. Pathol Res Pract (in press) Skinner J, Finlay JL, Sondel PM, Trigg ME (1986) Infectious complications in pediatric patients undergoing transplantation with T lymphocyte-depleted bone marrow. Pediatr Infect Dis 5:319–324 Starzl TE, Porter KA, Iwatsuki S, Rosenthal JT, Shaw BW, Atchinson RW, Nalesnik MA, Ho M, Griffith BP, Hakala TR, Hardesty RL, Jaffe R (1984) Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet 1:583 Tindle BH (1989) Pathology of infectious mononucleosis. In: Schlossberg D (ed) Infectious mononucleosis. Springer, Berlin Heidelberg New York Tokyo, 2nd edit, pp 126–141 Trigg ME, Billing R, Sondel PM, Exten R, Hong R, Bozdech MJ, Horowitz SD, Finlay JL, Moen R, Longo W, Erickson C, Peterson A (1985) Clinical trial depleting T lymphocytes from donor marrow for matched and mismatched allogeneic bone marrow transplants. Cancer Treat Rep 69:377–386 Trigg ME, de Alarcon P, Rumelhart S, Holida M, Giller R (1989) Alphainterferon therapy for lymphoproliferative disorders developing in two children following bone marrow transplants. J Biol Response Mod 8:603–613 Tutschka PJ, Beschorner WE, Hess AD, Santos GW (1983) Cyclosporin A to prevent graft-versus-host disease: a pilot study in 22 patients receiving allogeneic marrow transplants. Blood 62:318–324 Van Dongen JJM, Quertermous T, Bartram CR, Gold DP, Wolvers-Tettero JLM, Comans-Bitter WM, Hojkaas H, Adriaansen HJ, de Klein A, Raghavachar A, Ganser A, Duby AD, Seidman JG, van den Elsen P, Terhorst C (1987) T cell receptor CD3 complex during early T cell differentiation. Analysis of immature T cell acute lymphoblastic leukemias. (T-ALL) of DNA, RNA and cell membrane level. J Immunol 138: 1260–1269 Wagner JE, Yeager AM, Beschorner WE (1990) Pathology of bone marrow transplantation. In: Johnson F, Pochedly C (eds) Bone marrow transplantation in children. Raven Press, New York, pp 141–164 Weinstein HJ, Mayer RJ, Rosenthal DS, Coral FS, Camitta BM, Gelber RD (1983) Chemotherapy for acute myelogenous leukemia in children and adults. VAPA update. Blood 62:315–319 Weintraub J, Warnke RA (1982) Lymphoma in cardiac allotransplant recipients: Clinical and histological features and immunological phenotype. Transplantation 33:347–351 Witherspoon RP, Fisher LD, Schoch G, Martin P, Sullivan KM, Sanders J, Deeg HJ, Doney K, Thomas D, Storb R, Thomas ED (1989) Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. N Engl J Med 321:784–789 Yoshimoto S, Yano S, Yamashita M, Taguchi H, Kamimura Y, Ohtsuki Y, Miyoshi I (1985) Epstein-Barr virus-positive primary brain lymphoma complicating immunoblastic lymphadenopathy. Acta Haemat 74:114–115 Young L, Alfieri C, Hennessy K, Evans H, O’Hara C, Anderson KC, Ritz J, Shapiro RS, Rickinson A, Kieff E, Cohen JI (1989) Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N Engl J Med 321:1080–1085 Ziegler JL, Drew WL, Miner RC, Mintz L, Rosenbaum E, Gershow J, Lennett ET, Greenspan J, Shillitoe E, Beckstead J, Casavant C, Yamamoto K (1982) Outbreak of Burkitt’s lymphoma in homosexual men. Lancet 11:631–633 Zutter MM, Martin PJ, Sale GE, Shulman HM, Fisher L, Thomas ED, Durnam DM (1988) Epstein-Barr virus lymphoproliferation after bone marrow transplantation. Blood 72:520–529